Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Clin Cancer Res. 2010 Sep 16;16(21):5260–5268. doi: 10.1158/1078-0432.CCR-10-0994

Table 3.

Summary of Treatment Related Adverse Events

Total Grade ≥3
No. % No. %
Constitutional
 Fatigue 9 26 4 11
 Dehydration 2 6 1 3
 Anorexia 1 3 0

Gastrointestinal
 Mucositis 2 6 1 3
 Xerostomia 1 3 0
 Diarrhea 9 26 6 17
Nausea/Vomiting 3 9 0
 Dysphagia 1 3 0
 Odynophagia 2 6 1 3
 GI Bleed 5 14 2 (1 grade 5) 6
 Ulcer 1 3 0

Dermatologic
 Hand/Foot Syndrome 9 26 6 17

Pulmonary
 Hemoptysis 2 6 0

Cardiovascular
 Hypertension 1 3 0 0
 Supraventricular Tachycardia 2 6 2 6

Hemeatologic
 Leukopenia 11 31 11 31
 Neutropenia 12 34 12 34
 Anemia 2 6 2 6
 Thrombocytopenia 1 3 1 3

ENT
 Epistaxis 2 6 0
 Edema of Larynx 1 3 1 3

Endocrine
 Hypocalcemia 1 3 1 3

Neurologic
 Peripheral Neuropathy 1 3 1 3
Infection 2 6 1 3

Grade 3 and higher are reported in separate column

Abbreviations: ENT, ear, nose, and throat